Akèy › Maladi poumon entèstisyèl › Minnesota
Etid klinik pou Maladi poumon entèstisyèl nan Minnesota
15 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan Minnesota.
Vil nan Minnesota
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Minnesota, Minneapolis
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Minnesota, Minneapolis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester, Rochester
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07540988A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester, Rochester
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06806592Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Minnesota, Minneapolis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Mayo Clinic - Rochester, Rochester
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Mayo Clinic, Rochester
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Rochester, Rochester
Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Minnesota, Minneapolis
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Mayo Clinic, Rochester
Ap rekriteFaz 2
Laj 4 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Minnesota Health Clinical Research Unit (CRU), Minneapolis
- Mayo Clinic, Rochester
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- University of Minnesota, Minneapolis
Ap rekriteEtid obsèvasyon
Jiska laj 24 · Tout sèks · Mizajou Jun 22, 2026 · NCT04098445Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- Mayo Clinic, Rochester
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT03478826Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- University of Minnesota, Minneapolis
- Mayo Clinic in Rochester, Rochester
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT06751069Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
- Mayo Clinic in Rochester, Rochester
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jan 21, 2026 · NCT05120934Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.